Skip to content
Tirzepatide Report
Provider review

Cielo Tirzepatide Review: Monthly and Longer Plan Costs

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Compounded tirzepatide with monthly and longer-duration plans; clinical care through MD Integrations.

Standout details

  • Published monthly and longer-plan price table
  • Named clinical network: MD Integrations

Things to consider

  • $119/mo requires the twelve-month plan
  • Longer-plan payment schedule and refund calculation need confirmation

Cielo’s compounded tirzepatide page lists $189 for a monthly plan, falling to $149 per month for three months, $129 for six and $119 for twelve. The $119 headline belongs to the twelve-month option. These are duration-based prices, even though the site advertises the same price at any dose.3

The useful comparison is the actual amount due, care included and financial commitment. The public price table does not independently establish whether longer plans are collected upfront or in installments, or how an unused balance is treated if treatment stops.

Read the plan column beside the price

The product page shows $299 as a regular/reference amount beside the sale pricing. That is not the current listed monthly charge of $189. Do not combine a reference price, longest-term equivalent and another medication’s offer into a single tirzepatide quote.3

Swipe sideways to compare all columns →

PlanListed per-month amountFinancial detail to confirm
Monthly$189Next charge and supplied quantity
Three months$149Amount due and payment schedule
Six months$129Unused-balance treatment
Twelve months$119Full commitment and renewal rate
The table supplies monthly figures, not proof that longer plans are collected upfront.

Ask for the amount charged today, subsequent payment dates, total intended supply and renewal rate. Dose-independent pricing does not establish the concentration, number of vials or usable period. The ElitePhysiqMD review provides another setting for comparing a selected total rather than a headline alone.

What ongoing care is described

Cielo describes physician review, personalized dosing, ongoing follow-up, provider access and refill help. Its homepage says physician consultation and shipping are free; the product advertises expedited delivery. Confirm whether tests, future evaluations or other required services create additional charges.3,4

Its terms identify MD Integrations as the contracted provider network and explain that independent practitioners make clinical decisions. Eligibility requires age 18 or older. Obtain your clinician’s identity and verify service for your location instead of assuming that every medication is available everywhere.5

For different clinical arrangements, compare Care Clinics and Curex. Evaluate the actual services and follow-up available to you; a shared molecule does not make care packages equivalent.

Identify the dispenser before an order

Cielo refers generally to pharmacy partners but does not identify the facility assigned to an individual prescription. Ask for its legal name, contact details, preparation, concentration and intended supply. Use our pharmacy verification guide to match the assigned facility to the relevant state record and check the received label. General FDA-regulated-pharmacy wording is not approval of the compounded finished product.

The BiltRx review provides another pharmacy-disclosure comparison. Current licensing or certification should be checked through the responsible records, rather than inferred from the presence or absence of a website badge.

Cancellation needs a separate agreement

The public terms explain the platform and messaging service but do not supply a complete medication renewal deadline, pharmacy-processing cutoff or prepaid refund calculation. Their instructions to text STOP or unsubscribe concern messages; they should not be used as proof that a prescription subscription or payment has been canceled.5

ComponentConfirm in the selected agreement
MedicationPreparation, supply and dispensing facility
CareAssigned clinician, tests and extra charges
Future billingRenewal date and cancellation channel
Stopping treatmentCurrent order status and refund calculation
Unsubscribing from messages is not documentary cancellation of a medication order or subscription.

Before choosing a longer duration, obtain the selected commitment, cancellation method, next charge and amount refundable if the clinician changes the plan. Ask whether stopping a future renewal also stops any current medication order. Keep a confirmation that identifies the order and effective date.

Keep product evidence separate from convenience

Cielo explicitly names compounded tirzepatide. Compounded drugs are not FDA-approved, and the branded clinical trials do not establish the safety or effectiveness of every preparation.6,1,2 The compounding guide and evidence guide explain that distinction.

Discuss side effects, gallbladder concerns and the thyroid warning with your prescriber. For another service-disclosure comparison, see Coby Health; the provider comparison offers wider context.

Cielo’s published ladder and named clinical network give a useful starting point. The remaining decision depends on an actual payment schedule, supplied preparation, assigned pharmacy and written exit terms.

Frequently asked questions

What is Cielo’s monthly tirzepatide price?

The monthly option is $189. Longer plans list $149 per month for three months, $129 for six and $119 for twelve; confirm the payment schedule and total commitment.

Who provides clinical care?

The terms identify MD Integrations as the provider network and describe independent practitioners. Confirm your treating clinician and individual service eligibility.

Does texting STOP cancel the treatment plan?

The published STOP instructions concern text messages. Obtain separate confirmation of any prescription-order or subscription cancellation and its financial effect.

References(6)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Cielo Health (2026). Compounded tirzepatide price ladder and included care. Cielo Health.
  4. Cielo Health (2026). Consultation, shipping and ongoing care descriptions. Cielo Health.
  5. Cielo Health (2026). Terms of Service and provider network. Cielo Health.
  6. U.S. Food and Drug Administration (2026). Concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. Read source

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.